Medication info

Empagenta Tablets 25/5 mg (Empagliflozin, Linagliptin)

Prescription medicationTabletOral
Ingredient · strength
Empagliflozin›25mg / 1 tabletLinagliptin›5mg / 1 tablet
Manufacturer / importer
Daewon Pharmaceutical Co., Ltd.
Appearance
Pale pink triangular film-coated tablet
Packaging
30 tablets/box [10 tablets/PTP x 3]
Approval status
Active

MFDS item code 202503083 · Approved 2025.11.26

Summary

Main use
Improvement of glycemic control in patients with type 2 diabetes mellitus
Who takes it
Adults
Adult dose
The recommended starting dose of this medicine is empagliflozin 10 mg/linagliptin 5 mg once daily. For patients who tolerate empagliflozin 10 mg/linagliptin 5 mg but require additional glycemic control, the dose of this medicine may be increased to 25/5 mg once daily. Patients switching from combination therapy with empagliflozin and linagliptin to this medicine should receive the same doses they were previously taking. This medicine may be taken with or without food. Swallow the tablet whole. If you miss a dose, take it as soon as you remember. However, if it is within 12 hours of the next dose, skip the missed dose and take the next dose at the usual scheduled time. Do not take a double dose in one day. Patients with renal impairment This medicine is not recommended to improve glycemic control in patients with an estimated glomerular filtration rate (eGFR) below 45 ml/min/1.73m2. No dose adjustment is necessary in patients with an estimated glomerular filtration rate of 45 ml/min/1.73m2 or higher. Patients with hepatic impairment No dose adjustment is necessary in patients with mild or moderate hepatic impairment. Use of this medicine is not recommended in patients with severe hepatic impairment, as it has not been studied in this population. Older adults No dose adjustment is necessary based on age. In patients aged 75 years or older, renal function and the risk of volume depletion should be taken into consideration.

Ingredients

Manufacturer
Daewon Pharmaceutical Co., Ltd.

Efficacy & effects

Improvement of glycemic control in patients with type 2 diabetes mellitus

View approved original text

This medication is used in conjunction with diet and exercise to help control blood sugar in patients with type 2 diabetes. The combination of empagliflozin and linagliptin effectively manages blood sugar levels, which can improve symptoms of diabetes. This helps stabilize blood sugar levels and aids in the prevention of complications.

How to take

Adult dose

The recommended starting dose of this medicine is empagliflozin 10 mg/linagliptin 5 mg once daily. For patients who tolerate empagliflozin 10 mg/linagliptin 5 mg but require additional glycemic control, the dose of this medicine may be increased to 25/5 mg once daily. Patients switching from combination therapy with empagliflozin and linagliptin to this medicine should receive the same doses they were previously taking. This medicine may be taken with or without food. Swallow the tablet whole. If you miss a dose, take it as soon as you remember. However, if it is within 12 hours of the next dose, skip the missed dose and take the next dose at the usual scheduled time. Do not take a double dose in one day. Patients with renal impairment This medicine is not recommended to improve glycemic control in patients with an estimated glomerular filtration rate (eGFR) below 45 ml/min/1.73m2. No dose adjustment is necessary in patients with an estimated glomerular filtration rate of 45 ml/min/1.73m2 or higher. Patients with hepatic impairment No dose adjustment is necessary in patients with mild or moderate hepatic impairment. Use of this medicine is not recommended in patients with severe hepatic impairment, as it has not been studied in this population. Older adults No dose adjustment is necessary based on age. In patients aged 75 years or older, renal function and the risk of volume depletion should be taken into consideration.

Precautions

This medication consists of two active ingredients, empagliflozin and linagliptin, and is mainly used for the treatment of type 2 diabetes. This medication should not be administered to certain patients. For example, individuals who are allergic to empagliflozin, linagliptin, or any other components of this medication, patients with type 1 diabetes, diabetic ketoacidosis, patients undergoing renal dialysis, and individuals with lactose intolerance or related genetic issues should not take this medication. Patients with impaired kidney function may experience altered effectiveness from this medication, so regular monitoring of kidney function should be performed before and during treatment. Additionally, patients with heart failure should use this medication with caution and it is not recommended for patients with severe heart failure. This medication may cause rare side effects such as pancreatitis or bullous pemphigoid, so if severe abdominal pain or skin blisters occur during use, consult a doctor immediately. The most common side effect is urinary tract infection, and other potential effects include hypoglycemia, thirst, cough, constipation, itching, and rash. Caution is especially necessary when taken in conjunction with insulin or sulfonylureas as the risk of hypoglycemia may increase. This medication can cause fluid loss or low blood pressure, so use it carefully in individuals with low blood pressure or in the elderly. Additionally, though rare, a severe infection known as Fournier's gangrene may occur, so if there is pain, fever, or swelling around the genital area, immediate medical treatment should be sought. Pregnant or breastfeeding women are advised not to use this medication and it is not safe or effective for children under 18 years old. In the event of an overdose, seek medical attention immediately and keep out of reach of children. Lastly, this medication may have a mild effect on driving or operating machinery, so caution is needed, especially when taken with other medications that have a risk of hypoglycemia.

Side effects

  • urinary tract infection
  • vulvovaginitis
  • vulvitis
  • balanitis
  • other genital infections
  • hypersensitivity
  • angioedema
  • urticaria
  • hypoglycemia
  • thirst
Show 153 more
  • ketoacidosis
  • cough
  • constipation
  • pancreatitis
  • oral ulcer formation
  • itching
  • rash
  • vesicular pemphigoid
  • rhabdomyolysis
  • blood volume depletion
  • increased urination
  • dysuria
  • interstitial nephritis
  • increased amylase
  • increased lipase
  • increased hematocrit
  • increased serum lipids
  • increased serum creatinine
  • decreased glomerular filtration rate
  • abdominal pain
  • enterocolitis
  • bowel obstruction
  • gastroenteritis
  • herpes zoster
  • cystitis
  • acute pyelonephritis
  • bronchitis
  • vestibular neuronitis
  • sepsis
  • pneumonia
  • decreased appetite
  • dehydration
  • hyperglycemia
  • cerebral infarction
  • speech disorders
  • Alzheimer's dementia
  • chest pain
  • fever
  • facial swelling
  • fatigue
  • death
  • chronic obstructive pulmonary disease
  • asthma
  • diabetic foot
  • skin lesions
  • rhabdomyolysis
  • blood volume depletion
  • acute kidney injury
  • end-stage renal disease
  • acute cholangitis
  • acute cholecystitis
  • cholangitis
  • cholelithiasis
  • dizziness
  • anxiety
  • mood disorder
  • insomnia
  • depression
  • contusion
  • bone contusion
  • concussion
  • meniscus injury
  • bone fracture
  • hand fracture
  • pneumoconiosis
  • congestive heart failure
  • angina pectoris
  • acute myocardial infarction
  • unstable angina
  • cardiac arrest
  • diabetic retinopathy
  • dry eye
  • glaucoma
  • cataract
  • allergic conjunctivitis
  • polyuria
  • proteinuria
  • stress urinary incontinence
  • hematuria
  • hearing loss
  • erectile dysfunction
  • goiter
  • kidney transplant failure
  • anemia
  • lymphadenopathy
  • vulvar pruritus
  • genital pruritus
  • dyslipidemia
  • obesity
  • hypersomnia
  • hyponatremia
  • vitamin D deficiency
  • dermal cyst
  • seborrheic dermatitis
  • atopic dermatitis
  • nummular eczema
  • heat rash
  • sebaceous gland hyperplasia
  • lumbar spinal canal stenosis
  • myalgia
  • limb pain
  • musculoskeletal chest pain
  • arthralgia
  • cervical stenosis
  • fibromyalgia
  • flank pain
  • fracture pain
  • muscular weakness
  • osteoarthritis
  • osteoporosis
  • rotator cuff syndrome
  • astigmatism
  • allergic conjunctivitis
  • blurred vision
  • corneal erosion
  • macular fibrosis
  • eye discomfort
  • conjunctival injection
  • pathological myopia
  • retinal detachment
  • retinal crystals
  • retinal vein occlusion
  • traction retinal detachment
  • eyelid swelling
  • visual impairment
  • vitreous floaters
  • vitreous hemorrhage
  • epistaxis
  • exertional dyspnea
  • wet cough
  • allergic rhinitis
  • residual sputum
  • nosebleeds
  • oropharyngeal pain
  • voice disorders
  • exertional dyspnea
  • wet cough
  • runny nose
  • skin laceration
  • rib fracture
  • long ligament syndrome
  • angina pectoris
  • palpitations
  • Prinzmetal angina
  • coronary artery disease
  • tachycardia
  • arteriosclerosis
  • deep vein thrombosis
  • diabetic vascular complications
  • peripheral artery occlusive disease
  • unstable angina
  • hypertension
  • insomnia

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly sealed container to prevent exposure to air or moisture. Additionally, it is best to store the medication at room temperature, between 1 and 30 degrees Celsius, avoiding extremes of temperature.

Appearance and packaging

Appearance

Pale pink triangular film-coated tablet

Package unit

30 tablets/box [10 tablets/PTP x 3]

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.